CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results

Cellular immune responses have the potential to elicit dramatic and sustained clinical remissions in lymphoma patients. Recent clinical trial data demonstrate that modification of T cells with chimeric antigen receptors (CARs) is a promising strategy. T cells containing CARs with costimulatory domai...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Till, Brian G., Jensen, Michael C., Wang, Jinjuan, Qian, Xiaojun, Gopal, Ajay K., Maloney, David G., Lindgren, Catherine G., Lin, Yukang, Pagel, John M., Budde, Lihua E., Raubitschek, Andrew, Forman, Stephen J., Greenberg, Philip D., Riddell, Stanley R., Press, Oliver W.
格式: Artigo
語言:Inglês
出版: American Society of Hematology 2012
主題:
Clinical Trials and Observations
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3350361/
https://ncbi.nlm.nih.gov/pubmed/22308288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-10-387969
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍